Studies have shown that the expression of GLS in some breast cancer and nervous system tumors is higher than that in normal tissues, and the use of small molecule GLS inhibitors such as BPTES, CB-839 and compound 968 can significantly inhibit the growth of tumor cells (21, 100). Here, GLS is linked to breast carcinoma.